================================================================================

                                    FORM 8-K

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): July 23, 2003

                         REGENERATION TECHNOLOGIES, INC.
               --------------------------------------------------
               (Exact name of issuer as specified in its charter)

           DELAWARE                       0-31271               59-3466543
-------------------------------         -----------          ----------------
(State or other jurisdiction of         (Commission          (I.R.S. Employer
Incorporation or Organization)          File Number)        Identification No.)

                              11621 RESEARCH CIRCLE
                             ALACHUA, FLORIDA 32615
                    ----------------------------------------
                    (Address of Principal Executive Offices)

        Registrant's telephone number, including area code (386) 418-8888

                                      None
                -----------------------------------------------
                (Former address, if changed since last report.)

================================================================================


ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

      (c) Exhibit 99.1 Regeneration Technologies,  Inc. press release dated July
23, 2003.

ITEM 9. REGULATION FD DISCLOSURE

      On July 23, 2003, Regeneration Technologies,  Inc. announced its financial
results for the second quarter ended June 30, 2003. A copy of this press release
is furnished as an exhibit to this report on Form 8-K. The information contained
in this report on Form 8-K is being  furnished  pursuant to Item 12 under Item 9
of Form 8-K as  directed  by the U.S.  Securities  and  Exchange  Commission  in
Release No. 34-47583.

      (All other items on this report are inapplicable.)

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                   REGENERATION TECHNOLOGIES, INC.

                                   By /s/ Thomas F. Rose
                                      ------------------------------------------
                                      Thomas F. Rose
                                      Vice President and Chief Financial Officer

Dated: July 23, 2003


                                  EXHIBIT INDEX

99.1     Regeneration Technologies, Inc. press release, dated July 23, 2003.